196 related articles for article (PubMed ID: 31109081)
1.
Kim JY; Shim SH
Nutrients; 2019 May; 11(5):. PubMed ID: 31109081
[TBL] [Abstract][Full Text] [Related]
2. Anti-Atherosclerotic Effects of Fruits of
Kim JY; Shim SH
Biomolecules; 2019 Nov; 9(11):. PubMed ID: 31726713
[TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of total flavonoid fraction of the Epimedium koreanum Nakai extract on dopaminergic neurons: In vivo and in vitro.
Wu L; Du ZR; Xu AL; Yan Z; Xiao HH; Wong MS; Yao XS; Chen WF
Biomed Pharmacother; 2017 Jul; 91():656-663. PubMed ID: 28494419
[TBL] [Abstract][Full Text] [Related]
4. Epimedium koreanum Nakai and its main constituent icariin suppress lipid accumulation during adipocyte differentiation of 3T3-L1 preadipocytes.
Han YY; Song MY; Hwang MS; Hwang JH; Park YK; Jung HW
Chin J Nat Med; 2016 Sep; 14(9):671-676. PubMed ID: 27667512
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness of Prenyl Group on Flavonoids from
Choi HM; Kim JY; Li ZP; Jenis J; Ban YJ; Baiseitova A; Park KH
Molecules; 2019 Jan; 24(2):. PubMed ID: 30654565
[TBL] [Abstract][Full Text] [Related]
6. [The chemical constituents of Epimedium koreanum Nakai].
Sun P; Wen Y; Xu Y; Pei Y; Chen Y; Shimizu N; Takeda T
Yao Xue Xue Bao; 1998 Dec; 33(12):919-22. PubMed ID: 12016857
[TBL] [Abstract][Full Text] [Related]
7. Ethanol and water extract of purple sweet potato exhibits anti-atherosclerotic activity and inhibits protein glycation.
Park KH; Kim JR; Lee JS; Lee H; Cho KH
J Med Food; 2010 Feb; 13(1):91-8. PubMed ID: 20136441
[TBL] [Abstract][Full Text] [Related]
8. Chemical constituents from Epimedium koreanum Nakai and their chemotaxonomic significance.
Su XD; Li W; Ma JY; Kim YH
Nat Prod Res; 2018 Oct; 32(19):2347-2351. PubMed ID: 29157003
[TBL] [Abstract][Full Text] [Related]
9. Polysaccharides from Epimedium koreanum Nakai with immunomodulatory activity and inhibitory effect on tumor growth in LLC-bearing mice.
Wang C; Feng L; Su J; Cui L; Dan Liu ; Yan J; Ding C; Tan X; Jia X
J Ethnopharmacol; 2017 Jul; 207():8-18. PubMed ID: 28627460
[TBL] [Abstract][Full Text] [Related]
10. Effects of total flavonoids and flavonol glycosides from Epimedium koreanum Nakai on the proliferation and differentiation of primary osteoblasts.
Zhang DW; Cheng Y; Wang NL; Zhang JC; Yang MS; Yao XS
Phytomedicine; 2008 Jan; 15(1-2):55-61. PubMed ID: 17482445
[TBL] [Abstract][Full Text] [Related]
11. Prenylated Flavonoid Glycosides with PCSK9 mRNA Expression Inhibitory Activity from the Aerial Parts of
Kim E; Kim YM; Ahn J; Chae HS; Chin YW; Kim J
Molecules; 2021 Jun; 26(12):. PubMed ID: 34208231
[TBL] [Abstract][Full Text] [Related]
12. A new flavonol glycoside from the aerial parts of Epimedium koreanum Nakai.
Han F; Lee IS
Nat Prod Res; 2017 Feb; 31(3):320-325. PubMed ID: 27690633
[TBL] [Abstract][Full Text] [Related]
13. Effect of lipid-based suspension of Epimedium koreanum Nakai extract on sexual behavior in rats.
Makarova MN; Pozharitskaya ON; Shikov AN; Tesakova SV; Makarov VG; Tikhonov VP
J Ethnopharmacol; 2007 Dec; 114(3):412-6. PubMed ID: 17890032
[TBL] [Abstract][Full Text] [Related]
14. High-performance liquid chromatography-based multivariate analysis to predict the estrogenic activity of an Epimedium koreanum extract.
Islam MN; Kim U; Kim DH; Dong MS; Yoo HH
Biosci Biotechnol Biochem; 2012; 76(5):923-7. PubMed ID: 22738960
[TBL] [Abstract][Full Text] [Related]
15. Flavonoids from the leaves of
Zhang H; Wu X; Wang J; Wang M; Wang X; Shen T; Wang S; Ren D
Nat Prod Res; 2020 May; 34(9):1256-1263. PubMed ID: 30663372
[TBL] [Abstract][Full Text] [Related]
16. Epimedium koreanum Nakai displays broad spectrum of antiviral activity in vitro and in vivo by inducing cellular antiviral state.
Cho WK; Weeratunga P; Lee BH; Park JS; Kim CJ; Ma JY; Lee JS
Viruses; 2015 Jan; 7(1):352-77. PubMed ID: 25609307
[TBL] [Abstract][Full Text] [Related]
17. Comparison between HPLC and HPTLC densitometry for the determination of icariin from Epimedium koreanum extracts.
Pozharitskaya ON; Kosman VM; Shikov AN; Demchenko DV; Eschenko AY; Makarov VG
J Sep Sci; 2007 Mar; 30(5):708-12. PubMed ID: 17461110
[TBL] [Abstract][Full Text] [Related]
18. Potential of Icariin Metabolites from Epimedium koreanum Nakai as Antidiabetic Therapeutic Agents.
Kim DH; Jung HA; Sohn HS; Kim JW; Choi JS
Molecules; 2017 Jun; 22(6):. PubMed ID: 28608833
[TBL] [Abstract][Full Text] [Related]
19. An integrated plasma and urinary metabonomic study using UHPLC-MS: intervention effects of Epimedium koreanum on 'Kidney-Yang Deficiency syndrome' rats.
Huang D; Yang J; Lu X; Deng Y; Xiong Z; Li F
J Pharm Biomed Anal; 2013 Mar; 76():200-6. PubMed ID: 23333940
[TBL] [Abstract][Full Text] [Related]
20. Synergistic or antagonistic effect of MTE plus TF or icariin from Epimedium koreanum on the proliferation and differentiation of primary osteoblasts in vitro.
Zhang J; Li Y; Sun J; Liu C; Zhang D
Biol Trace Elem Res; 2011 Dec; 143(3):1746-57. PubMed ID: 21301987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
